troxacitabine has been researched along with guanfacine in 1 studies
Studies (troxacitabine) | Trials (troxacitabine) | Recent Studies (post-2010) (troxacitabine) | Studies (guanfacine) | Trials (guanfacine) | Recent Studies (post-2010) (guanfacine) |
---|---|---|---|---|---|
72 | 17 | 2 | 784 | 180 | 273 |
Protein | Taxonomy | troxacitabine (IC50) | guanfacine (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 1.453 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.134 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.249 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 6.447 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 3.014 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 1.453 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 2.098 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
1 other study(ies) available for troxacitabine and guanfacine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |